Ventilator associated pneumoniae (VAP) is a major burden of healthcare associated infections (HAI) and leading cause of death of mortality and morbidity in critical care patients. NHSN 2010 reported a VAP pooled mean of 1.2 per 1000 ventilator days. The INICC study reported higher VAP rates in developing countries. VAP rates of 10.4 were reported from India. Surveillance has always been an effective tool for reduction of VAP worldwide. The importance of surveillance is not only to detect infection risk, process and outcome but also as a tool for recognizing outbreaks.